Which ICD‑10 diagnosis code should be used when ordering Seroquel (quetiapine) and Caplyta (lumateperone) for a patient?

ICD-10 Diagnosis Codes for Ordering Seroquel and Caplyta

The appropriate ICD-10 code depends entirely on the specific psychiatric diagnosis being treated—you cannot order these medications without documenting the underlying condition they are intended to treat.

Understanding the Clinical Context

Seroquel (quetiapine) and Caplyta (lumateperone) are atypical antipsychotics with distinct FDA-approved indications that determine which ICD-10 codes are appropriate:

Seroquel (Quetiapine) - Common ICD-10 Codes:

• F20.9 - Schizophrenia, unspecified (or more specific F20.0-F20.89 codes based on subtype)
• F31.0-F31.9 - Bipolar disorder codes (for acute mania or mixed episodes)
• F06.2 - Psychotic disorder due to known physiological condition
• R45.1 - Restlessness and agitation (when used for delirium management in specific settings) 1

Quetiapine is used off-label for various conditions including delirium (starting dose 25 mg PO, sedating, less likely to cause extrapyramidal symptoms) 1 and behavioral disturbances in dementia (initial 12.5 mg twice daily, maximum 200 mg twice daily) 2.

Caplyta (Lumateperone) - FDA-Approved ICD-10 Codes:

• F20.9 - Schizophrenia, unspecified (FDA-approved for adults) 3
• F31.31 - Bipolar disorder, current episode depressed, mild
• F31.32 - Bipolar disorder, current episode depressed, moderate
• F31.4 - Bipolar disorder, current episode depressed, severe
• F31.5 - Bipolar disorder, current episode depressed with psychotic features

Caplyta is specifically FDA-approved for schizophrenia and depressive episodes associated with bipolar I or II disorder (bipolar depression), both as monotherapy and as adjunctive therapy with lithium or valproate 3. The standard dose is 42 mg once daily.

For Major Depressive Disorder with Mixed Features:

• F32.81 - Premenstrual dysphoric disorder (if applicable)
• F32.89 - Other specified depressive episodes
• F33.8 - Other recurrent depressive disorders

Recent evidence shows lumateperone is effective for MDD with mixed features 4 and has been approved as adjunctive treatment for MDD 5.

Critical Documentation Requirements

You must document:

1. The specific psychiatric diagnosis using the most precise ICD-10 code available (not just "unspecified")
2. Current symptom severity (mild, moderate, severe, with psychotic features)
3. Treatment rationale - why this specific medication is appropriate for this diagnosis
4. Prior treatment history if applicable (especially for off-label uses)

Common Pitfalls to Avoid

• Never use vague codes like R45.87 (impulsivity) or R45.851 (suicidal ideations) as primary diagnoses for antipsychotic orders—these are symptoms, not diagnoses
• Don't use substance-induced codes (F1x.xx series) unless the psychosis is truly substance-induced
• Avoid using "unspecified" codes when more specific information is available in the medical record
• For bipolar depression, specify whether it's bipolar I (F31.3x) or bipolar II (F31.81) as this affects treatment algorithms 6

Insurance Authorization Considerations

Most insurers require:

• Schizophrenia codes (F20.x) for Caplyta will typically be approved based on FDA indication 3
• Bipolar depression codes (F31.3x-F31.5) for Caplyta are FDA-approved and should be covered 3
• Off-label uses (delirium, dementia-related psychosis) may require additional documentation of medical necessity and prior authorization

The bottom line: Match your ICD-10 code precisely to the documented psychiatric diagnosis and FDA-approved indication whenever possible to ensure appropriate prescribing and reimbursement.